[Skip navigation]FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
Powered by Google

 Talk Papers
Therapeutic Biological Products

horizonal rule

FDA Approves First Treatment for Genetic Metabolic Disorder Including Hurler Disorder - 4/30/2003

FDA Approves First Treatment for Fabry Disease - 4/24/2003

FDA Statement on Counterfeit Procrit - 3/11/2003

FDA Approves First Biologic Therapy for Psoriasis - 1/31/2003

FDA Approves BOTOX To Treat Frown Lines - 4/15/2002

FDA Approves First Radiopharmaceutical Product to Treat Non-Hodgkin's Lymphoma - 2/20/2002

FDA Approves First Biologic Treatment for Sepsis - 11/21/2001

FDA Approves Stand-Alone Package of Ribavirin for Combination Therapy with Intron A for Treatment of Chronic Hepatitis C Infection - 7/26/2001

Serious Manufacturing Deficiencies with Abbokinase Prompt FDA Letter to Abbott Labs - 7/16/1999

FDA Approves Novel Treatment for Rare Form of Cancer - Denileukin diftitox (Ontak), Seragen, Inc. - 2/5/1999

First Biotechnology Product for Arthritis Approved - HHS News - Etanercept (Enbrel), Immunex Corp. - 11/2/1998

New Monoclonal Antibody Approved for Advanced Breast Cancer - HHS News - Trastuzumab (Herceptin), Genentech, Inc. - 9/25/1998

First Treatment for Crohn's Disease Approved - HHS News - Infliximab (Remicade), Centecor, Inc. - 8/24/1998

FDA Licenses Biotech Product to Prevent Serious RSV Disease - Palivizumab (Synagis), MedImmune, Inc. - 6/19/1998

FDA Clears New Hepatitis C Treatment for Marketing - 6/3/1998

New Biotech Product for Diabetic Ulcers - Becaplermin (Regranex), OMJ Pharmaceuticals, Inc. - 12/16/1997

New Biotechnology Product Approved to Help Prevent Rejection of Kidney Transplants - Daclizumab (Zenapax), Hoffman-La Roche Inc. - 12/11/1997

First Monoclonal Antibody Approved to Treat Cancer - Rituximab (Rituxan), Genentech, Inc. - 11/26/1997

New Biotech Product Approved to Reduce Need for Chemotherapy-Related Platelet Transfusions - Oprelvekin (Neumega), Genetics Institute, Inc. - 11/25/1997

Back to Top     Back to Index

Date created: September 25, 2003

horizonal rule